FMR1 Reactivating Treatments in Fragile X iPSC-Derived Neural Progenitors In Vitro and In Vivo
2019 · Cell Reports · 37 citations
https://doi.org/10.1016/j.celrep.2019.02.026
T
Tamar Golan‐Lev
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
1.7K
Citations
17
h-index
20
i10-index
Tamar Golan‐Lev is an academic researcher from Hebrew University of Jerusalem. The author has contributed to research in topics: Pluripotent Stem Cells Research & CRISPR and Genetic Engineering & Renal and related cancers. The author has an h-index of 17, co-authored 23 publications.
Papers by this author
worksThe Chromatin Regulator ZMYM2 Restricts Human Pluripotent Stem Cell Growth and Is Essential for Teratoma Formation
2020 · Stem Cell Reports · 24 citations
https://doi.org/10.1016/j.stemcr.2020.05.014
Genome-wide Screen for Culture Adaptation and Tumorigenicity-Related Genes in Human Pluripotent Stem Cells
2019 · iScience · 11 citations
https://doi.org/10.1016/j.isci.2018.12.031
Generation, genomic characterization, and differentiation of triploid human embryonic stem cells
2023 · Stem Cell Reports · 5 citations
https://doi.org/10.1016/j.stemcr.2023.04.001
Genome-wide screening reveals essential roles for HOX genes and imprinted genes during caudal neurogenesis of human embryonic stem cells
2024 · Stem Cell Reports · 1 citations
https://doi.org/10.1016/j.stemcr.2024.09.009
Predicting tumour resistance to paclitaxel and carboplatin utilising genome‐wide screening in haploid human embryonic stem cells
2024 · Cell Proliferation · 1 citations
https://doi.org/10.1111/cpr.13771
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat